Mycophenolate Mofetil 250 mg/1

Mycophenolate Mofetil 250 mg capsules are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Hikma Pharmaceuticals USA Inc.

Mycophenolate Mofetil is primarily used to prevent rejection of transplanted organs, such as kidneys, heart, or liver. It works by suppressing the immune system to reduce the risk of the body attacking the new organ. This medication is often prescribed in combination with other immunosuppressants to enhance effectiveness. Patients should consult their healthcare provider to understand the specific uses of Mycophenolate Mofetil for their condition.

Common effects of Mycophenolate Mofetil may include nausea, vomiting, diarrhea, and abdominal pain. Some users may also experience fatigue, headache, or infections due to the immunosuppressant nature of the medication. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Mycophenolate Mofetil should be handled with care, as it can increase the risk of infections and certain types of cancer. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should avoid activities that may increase the risk of injury or infection while taking this medication.

Mycophenolate Mofetil may interact with other medications, including antacids, cholestyramine, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be avoided as it may exacerbate the side effects of this medication.